Авторы

  • Kurbanova Z.Ch., Tojiboyeva D.A., Sayfutdinova Z.A.

Ключевые слова:

chronic kidney disease, leukocyte, erythrocyte, cylinder, urine.

Библиографические ссылки

Ivanov D.D., Kuryata A.V., Garmish I.P. (2018) Blockatory RAAS.

Ikramova L.B., Skosyreva O.V., Jabbarov A.A., Babadzhanova N.R. Evaluation of the effectiveness of enterosgelya and correction of endotoxicosis in patients with chronic lung disease III stage: scientific publication // Terapevticheskiy vestnik Uzbekistana. Tashkent, 2014. C. 161.

Iskanderova S.D., Kuldashev T.A. The state of lipid exchange in patients with chronic pyelonephritis in combination with arterial hypertension and chronic kidney disease: scientific publication // Terapevticheskiy vestnik Uzbekistana. - Tashkent, 2013. - N4. - C. 232

Beck, L. H. Jr., Bonegio, R. G., Lambeau, G., et al. (2009). M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. The New England Journal of Medicine, 361(1), 11–21.

Ronco, P., & Debiec, H. (2020). Pathophysiological advances in membranous nephropathy: Time for a shift in diagnosis and therapy. Nature Reviews Nephrology, 16(8), 445–458.

KDIGO Clinical Practice Guideline for Glomerular Diseases (2021). Kidney International Supplements, 11(3), 139–274.

Glassock, R. J. (2017). The pathogenesis of idiopathic membranous nephropathy: A 50-year odyssey. American Journal of Kidney Diseases, 69(3), 354–367.

Alimov, A. N., et al. (2023). Changes in immune parameters in patients with chronic glomerulonephritis. Bulletin of the Tashkent Medical Academy, No. 2, 44–49.

Ministry of Health of Uzbekistan. (2024). Clinical protocols for the diagnosis and treatment of kidney diseases. Tashkent.